{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:32:29Z","timestamp":1791322349824,"version":"4.3.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1378\/chest.12-0741","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T07:25:10Z","timestamp":1362468310000},"page":"814-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":273,"title":["Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Rekha","family":"Vij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Strek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1378\/chest.12-0741_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-0741_bib2","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1378\/chest.130.5.1566","article-title":"Cellular vs fibrosing interstitial pneumonias and prognosis: a practical classification of the idiopathic interstitial pneumonias and pathologically\/radiologically similar conditions","volume":"130","author":"Churg","year":"2006","journal-title":"Chest"},{"issue":"suppl 5","key":"10.1378\/chest.12-0741_bib3","first-page":"v1","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society [published correction in Thorax. 2008;63(11):1029]","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"issue":"8","key":"10.1378\/chest.12-0741_bib4","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/art.30423","article-title":"Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies","volume":"63","author":"Le Pavec","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1378\/chest.12-0741_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1378\/chest.12-0741_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/acr.20684","article-title":"Validation of potential classification criteria for systemic sclerosis","volume":"64","author":"Johnson","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1378\/chest.12-0741_bib7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2007.069518","article-title":"Scleroderma Lung Study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis","volume":"66","author":"Clements","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1378\/chest.12-0741_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1378\/chest.12-0741_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","article-title":"Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence","volume":"40","author":"Christmann","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1378\/chest.12-0741_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ard.2007.081612","article-title":"Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1378\/chest.12-0741_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring","volume":"179","author":"Savarino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.12-0741_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000156958","article-title":"Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis","volume":"77","author":"de Souza","year":"2009","journal-title":"Respiration"},{"issue":"4","key":"10.1378\/chest.12-0741_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.1780340405","article-title":"Predictors of survival in systemic sclerosis (scleroderma)","volume":"34","author":"Altman","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1378\/chest.12-0741_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest"},{"issue":"11","key":"10.1378\/chest.12-0741_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1378\/chest.12-0741_bib16","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/art.30438","article-title":"Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease","volume":"63","author":"Roth","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"25","key":"10.1378\/chest.12-0741_bib17","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.12-0741_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","article-title":"Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease","volume":"176","author":"Tashkin","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-0741_bib19","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2534","article-title":"Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies","volume":"10","author":"Nannini","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1378\/chest.12-0741_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1378\/chest.12-0741_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rmed.2007.07.021","article-title":"Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease","volume":"102","author":"Zamora","year":"2008","journal-title":"Respir Med"},{"issue":"11","key":"10.1378\/chest.12-0741_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10067-011-1823-1","article-title":"Effect of mycophenolate sodium in scleroderma-related interstitial lung disease","volume":"30","author":"Sime\u00f3n-Aznar","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1378\/chest.12-0741_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1378\/chest.06-2861","article-title":"Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease","volume":"133","author":"Gerbino","year":"2008","journal-title":"Chest"},{"key":"10.1378\/chest.12-0741_bib24","author":"National Heart, Lung, and Blood Institute"},{"issue":"9790","key":"10.1378\/chest.12-0741_bib25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1378\/chest.12-0741_bib26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/kem357","article-title":"Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab","volume":"47","author":"McGonagle","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1378\/chest.12-0741_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00296-009-1347-z","article-title":"Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab","volume":"32","author":"Yoo","year":"2012","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1378\/chest.12-0741_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1753465811407786","article-title":"Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids","volume":"5","author":"Haroon","year":"2011","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"10.1378\/chest.12-0741_bib29","first-page":"23","article-title":"Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease","volume":"25","author":"Antoniou","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1378\/chest.12-0741_bib30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"3 pt 1","key":"10.1378\/chest.12-0741_bib31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1164\/ajrccm.154.3.8810621","article-title":"Interstitial lung disease in primary Sj\u00f6gren's syndrome. Clinical-pathological evaluation and response to treatment","volume":"154","author":"Deheinzelin","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-0741_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccm.2010.05.006","article-title":"Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases","volume":"31","author":"Meyer","year":"2010","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1378\/chest.12-0741_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccm.2010.05.008","article-title":"Pulmonary manifestations of the idiopathic inflammatory myopathies","volume":"31","author":"Kalluri","year":"2010","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1378\/chest.12-0741_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/03009742.2011.599072","article-title":"Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade","volume":"40","author":"Mohr","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1378\/chest.12-0741_bib35","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/acr.20212","article-title":"Mycophenolate mofetil for interstitial lung disease in dermatomyositis","volume":"62","author":"Morganroth","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1378\/chest.12-0741_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10067-009-1358-x","article-title":"Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine","volume":"29","author":"Ando","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1378\/chest.12-0741_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/rheumatology\/kep398","article-title":"Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil","volume":"49","author":"Launay","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1378\/chest.12-0741_bib38","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1378\/chest.12-0741_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1378\/chest.12-0741_bib40","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1378\/chest.12-0741_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11926-010-0116-z","article-title":"Interstitial lung disease in rheumatoid arthritis","volume":"12","author":"Ascherman","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1378\/chest.12-0741_bib42","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.12-0741_bib43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.12-0741_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1378\/chest.08-2572","article-title":"Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia","volume":"136","author":"Song","year":"2009","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.12-0741_bib45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1183\/09031936.00152607","article-title":"Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement","volume":"33","author":"Antoniou","year":"2009","journal-title":"Eur Respir J"},{"issue":"15","key":"10.1378\/chest.12-0741_bib46","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinte.168.15.1718","article-title":"Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug","volume":"168","author":"Saketkoo","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.12-0741_bib47","author":"Matteson"},{"issue":"6","key":"10.1378\/chest.12-0741_bib48","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1378\/chest.12-0741_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1378\/chest.12-0741_bib50","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/rheumatology\/kep050","article-title":"Clinical expression of leflunomide-induced pneumonitis","volume":"48","author":"Chikura","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1378\/chest.12-0741_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1183\/09031936.00080209","article-title":"Rituximab-induced lung disease: A systematic literature review","volume":"35","author":"Liot\u00e9","year":"2010","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1378\/chest.12-0741_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rdc.2011.01.001","article-title":"Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features","volume":"37","author":"Khan","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1378\/chest.12-0741_bib53","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1378\/chest.08-2740","article-title":"Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis","volume":"136","author":"Mukae","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.12-0741_bib54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern Med"},{"issue":"6","key":"10.1378\/chest.12-0741_bib55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1378\/chest.12-0741_bib56","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.08-0943","article-title":"Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports","volume":"134","author":"Fern\u00e1ndez","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.12-0741_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0b013e31817d116f","article-title":"Malignancy in the setting of the anti-synthetase syndrome","volume":"14","author":"Rozelle","year":"2008","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"10.1378\/chest.12-0741_bib58","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.08-2233","article-title":"Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature","volume":"135","author":"Kalluri","year":"2009","journal-title":"Chest"},{"issue":"9","key":"10.1378\/chest.12-0741_bib59","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","article-title":"Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients","volume":"29","author":"V\u00e1ncsa","year":"2009","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1378\/chest.12-0741_bib60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/RHU.0b013e3181b0e910","article-title":"Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience","volume":"15","author":"Mileti","year":"2009","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1378\/chest.12-0741_bib61","first-page":"260","article-title":"High-resolution computed tomography characterization of interstitial lung diseases in polymyositis\/dermatomyositis","volume":"35","author":"Hayashi","year":"2008","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1378\/chest.12-0741_bib62","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1378\/chest.10-0360","article-title":"Polymyositis associated with severe interstitial lung disease: remission after three doses of IV immunoglobulin","volume":"139","author":"Bakewell","year":"2011","journal-title":"Chest"},{"issue":"12","key":"10.1378\/chest.12-0741_bib63","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00296-009-0859-x","article-title":"Rituximab in life threatening antisynthetase syndrome","volume":"29","author":"Vandenbroucke","year":"2009","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1378\/chest.12-0741_bib64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005382-200110000-00009","article-title":"Lung manifestation in asymptomatic patients with primary Sj\u00f6gren syndrome: assessment with high resolution CT and pulmonary function tests","volume":"16","author":"Uffmann","year":"2001","journal-title":"J Thorac Imaging"},{"issue":"6","key":"10.1378\/chest.12-0741_bib65","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1378\/chest.12-0741_bib66","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","article-title":"Pulmonary manifestations of primary Sj\u00f6gren's syndrome: a clinical, radiologic, and pathologic study","volume":"171","author":"Ito","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1378\/chest.12-0741_bib67","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","article-title":"Lung involvement in patients with primary Sj\u00f6gren's syndrome: what are the predictors?","volume":"30","author":"Yazisiz","year":"2010","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1378\/chest.12-0741_bib68","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","article-title":"Interstitial lung disease in primary Sj\u00f6gren syndrome","volume":"130","author":"Parambil","year":"2006","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.12-0741_bib69","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ccm.2010.05.007","article-title":"Pulmonary involvement in Sj\u00f6gren syndrome","volume":"31","author":"Kokosi","year":"2010","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1378\/chest.12-0741_bib70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10067-006-0351-x","article-title":"Lymphocytic interstitial pneumonitis (LIP) in Sj\u00f6gren's syndrome: a case report and a review of the literature","volume":"26","author":"Dalvi","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1378\/chest.12-0741_bib71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u00f6gren's syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1378\/chest.12-0741_bib72","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","article-title":"Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?","volume":"176","author":"Kinder","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-0741_bib73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1183\/09031936.00174910","article-title":"Significance of connective tissue disease features in idiopathic interstitial pneumonia","volume":"39","author":"Corte","year":"2012","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.12-0741_bib74","first-page":"615","article-title":"Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria","volume":"17","author":"Mosca","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1378\/chest.12-0741_bib75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10067-009-1175-2","article-title":"Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients","volume":"28","author":"Vaz","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1378\/chest.12-0741_bib76","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.10-0194","article-title":"Connective tissue disease-associated interstitial lung disease: a call for clarification","volume":"138","author":"Fischer","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.12-0741_bib77","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1378\/chest.10-2662","article-title":"Autoimmune-featured interstitial lung disease: a distinct entity","volume":"140","author":"Vij","year":"2011","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213601646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213601646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:36:33Z","timestamp":1757918193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213601646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0012369213601646"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-0741","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-0741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}